Free Trial

190,900 Shares of Hinge Health Inc. $HNGE Acquired by Alberta Investment Management Corp

Hinge Health logo with Healthcare background
Image from MarketBeat Media, LLC.

Alberta Investment Management Corp purchased a new position in Hinge Health Inc. (NYSE:HNGE - Free Report) in the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 190,900 shares of the company's stock, valued at approximately $18,563,000. Alberta Investment Management Corp owned 0.24% of Hinge Health at the end of the most recent reporting period.

Other hedge funds have also modified their holdings of the company. Mirae Asset Global Investments Co. Ltd. bought a new stake in Hinge Health during the 3rd quarter valued at approximately $2,520,000. Assenagon Asset Management S.A. lifted its holdings in Hinge Health by 2,141.9% in the 3rd quarter. Assenagon Asset Management S.A. now owns 1,854,922 shares of the company's stock worth $180,373,000 after purchasing an additional 1,772,182 shares in the last quarter. Argent Capital Management LLC bought a new position in Hinge Health in the 3rd quarter worth approximately $3,376,000. Vista Investment Partners LLC bought a new position in Hinge Health in the 2nd quarter worth approximately $3,468,000. Finally, 11.2 Capital Management LLC purchased a new stake in Hinge Health during the 2nd quarter valued at approximately $204,566,531.

Wall Street Analyst Weigh In

Several equities analysts have weighed in on the company. Canaccord Genuity Group raised their price target on Hinge Health from $105.00 to $134.00 and gave the company a "buy" rating in a report on Tuesday, November 3rd. Citizens Jmp upped their price objective on Hinge Health from $96.00 to $107.00 and gave the stock a "market outperform" rating in a report on Wednesday, August 5th. Robert W. Baird increased their target price on Hinge Health from $85.00 to $90.00 and gave the company a "neutral" rating in a research report on Tuesday, September 22nd. Weiss Ratings raised shares of Hinge Health from a "hold (c-)" rating to a "hold (c)" rating in a report on Tuesday, November 10th. Finally, Morgan Stanley raised their target price on shares of Hinge Health from $117.00 to $131.00 and gave the company an "overweight" rating in a report on Tuesday, November 3rd. Two equities research analysts have rated the stock with a Strong Buy rating, fifteen have issued a Buy rating and two have assigned a Hold rating to the company's stock. According to data from MarketBeat, Hinge Health has an average rating of "Buy" and a consensus price target of $118.93.

View Our Latest Research Report on HNGE

Insider Buying and Selling at Hinge Health

In other news, President James Pursley sold 33,000 shares of the business's stock in a transaction dated Monday, September 21st. The shares were sold at an average price of $94.14, for a total value of $3,106,620.00. Following the completion of the sale, the president owned 666,909 shares in the company, valued at approximately $62,782,813.26. The trade was a 4.71% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Chairman Gabriel Mecklenburg sold 200,000 shares of Hinge Health stock in a transaction on Wednesday, November 11th. The shares were sold at an average price of $122.41, for a total value of $24,482,000.00. Following the completion of the transaction, the chairman owned 200,000 shares in the company, valued at $24,482,000. This represents a 50.00% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last 90 days, insiders have sold 1,260,488 shares of company stock worth $124,481,770. 18.92% of the stock is owned by company insiders.

Hinge Health Stock Performance

Shares of NYSE HNGE opened at $115.22 on Monday. Hinge Health Inc. has a fifty-two week low of $30.08 and a fifty-two week high of $126.40. The company has a market cap of $9.36 billion, a price-to-earnings ratio of 58.78, a PEG ratio of 1.63 and a beta of 1.19. The business's 50 day moving average price is $103.82 and its 200-day moving average price is $70.81.

Hinge Health (NYSE:HNGE - Get Free Report) last posted its quarterly earnings results on Monday, November 2nd. The company reported $0.71 earnings per share for the quarter, beating the consensus estimate of $0.27 by $0.44. The firm had revenue of $234.97 million during the quarter. Hinge Health had a net margin of 21.02% and a return on equity of 66.96%. The business's revenue was up 52.4% on a year-over-year basis. During the same period in the prior year, the firm posted ($0.02) EPS. Sell-side analysts predict that Hinge Health Inc. will post 1.56 earnings per share for the current year.

Hinge Health Profile

(Free Report)

Hinge Health is a digital health company focused on musculoskeletal care, including support for people with back, joint and muscle pain. Its services are designed to help members manage conditions through personalized, technology-enabled care. The company's offerings include app-based exercise therapy, education and behavioral support, along with access to clinical care teams. Hinge Health also uses wearable motion sensors in some programs to guide and track exercises. Founded in 2015, Hinge Health primarily provides its services through employers and health plans.

Featured Articles

Institutional Ownership by Quarter for Hinge Health (NYSE:HNGE)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Hinge Health Right Now?

Before you consider Hinge Health, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Hinge Health wasn't on the list.

While Hinge Health currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Energy Stocks to Buy and Hold Forever Cover

Oil still powers the global economy, but AI is reshaping the energy opportunity. Discover seven stocks spanning traditional energy, infrastructure, and next-generation power.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines